Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56551 - 56575 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	PRKCB	5579	upregulated	panobinostat results in increased expression of PRKCB mRNA	16p12.2-p12.1	A21037
Panobinostat	Approved Investigational	PRKCH	5583	upregulated	panobinostat results in increased expression of PRKCH mRNA	14q23.1	A21037
Panobinostat	Approved Investigational	PRNP	5621	upregulated	panobinostat results in increased expression of PRNP mRNA	20p13	A21037
Panobinostat	Approved Investigational	PRODH	5625	upregulated	panobinostat results in increased expression of PRODH mRNA	22q11.21	A21037
Panobinostat	Approved Investigational	PROK2	60675	downregulated	panobinostat results in decreased expression of PROK2 mRNA	3p13	A21037
Panobinostat	Approved Investigational	PRR15	222171	upregulated	panobinostat results in increased expression of PRR15 mRNA	7p14.3	A21037
Panobinostat	Approved Investigational	PRR16	51334	upregulated	panobinostat results in increased expression of PRR16 mRNA	5q23.1	A21037
Panobinostat	Approved Investigational	PRRG1	5638	upregulated	panobinostat results in increased expression of PRRG1 mRNA	Xp21.1	A21037
Panobinostat	Approved Investigational	PRRX1	5396	upregulated	panobinostat results in increased expression of PRRX1 mRNA	1q24.2	A21037
Panobinostat	Approved Investigational	PRSS12	8492	upregulated	panobinostat results in increased expression of PRSS12 mRNA	4q26	A21037
Panobinostat	Approved Investigational	PRSS23	11098	downregulated	panobinostat results in decreased expression of PRSS23 mRNA	11q14.2	A21037
Panobinostat	Approved Investigational	PRSS8	5652	upregulated	panobinostat results in increased expression of PRSS8 mRNA	16p11.2	A21037
Panobinostat	Approved Investigational	PRUNE2	158471	downregulated	panobinostat results in decreased expression of PRUNE2 mRNA	9q21.2	A21037
Panobinostat	Approved Investigational	PTCHD1	139411	upregulated	panobinostat results in increased expression of PTCHD1 mRNA	Xp22.11	A21037
Panobinostat	Approved Investigational	PTGER4	5734	upregulated	panobinostat results in increased expression of PTGER4 mRNA	5p13.1	A21037
Panobinostat	Approved Investigational	PTGS1	5742	downregulated	panobinostat results in decreased expression of PTGS1 mRNA	9q33.2	A21037
Panobinostat	Approved Investigational	PTPN5	84867	downregulated	panobinostat results in decreased expression of PTPN5 mRNA	11p15.1	A21037
Panobinostat	Approved Investigational	PTPRN2	5799	downregulated	panobinostat results in decreased expression of PTPRN2 mRNA	7q36.3	A21037
Panobinostat	Approved Investigational	PTPRO	5800	downregulated	panobinostat results in decreased expression of PTPRO mRNA	12p12.3	A21037
Panobinostat	Approved Investigational	PURG	29942	downregulated	panobinostat results in decreased expression of PURG mRNA	8p12	A21037
Panobinostat	Approved Investigational	PXDC1	221749	upregulated	panobinostat results in increased expression of PXDC1 mRNA	6p25.2	A21037
Panobinostat	Approved Investigational	PYCARD	29108	upregulated	panobinostat results in increased expression of PYCARD mRNA	16p11.2	A21037
Panobinostat	Approved Investigational	RAB11FIP4	84440	upregulated	panobinostat results in increased expression of RAB11FIP4 mRNA	17q11.2	A21037
Panobinostat	Approved Investigational	RAB17	64284	upregulated	panobinostat results in increased expression of RAB17 mRNA	2q37.3	A21037
Panobinostat	Approved Investigational	RAB20	55647	upregulated	panobinostat results in increased expression of RAB20 mRNA	13q34	A21037

Displaying entries 56551 - 56575 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability